We are live on ! Find out more
EWA

EverSource Wealth Advisors Portfolio holdings

AUM $2.97B
1-Year Est. Return 28.72%
This Fund
S&P 500
This Quarter Est. Return
+3.37%
1 Year Est. Return
+28.72%
3 Year Est. Return
+89.67%
5 Year Est. Return
10 Year Est. Return
AUM
$1.78B
AUM Growth
+$200M
Cap. Flow
+$179M
Cap. Flow %
10.05%
Top 10 Hldgs %
22.92%
Holding
3,857
New
813
Increased
1,811
Reduced
743
Closed
107

Sector Composition

Rank Sector Weight
1 Technology 12.25%
2 Financials 6.72%
3 Consumer Discretionary 6.69%
4 Industrials 3.41%
5 Communication Services 2.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EVV
1801
Eaton Vance Limited Duration Income Fund
EVV
$1.07B
$14.7K ﹤0.01%
1,500
ABCL icon
1802
AbCellera Biologics
ABCL
$2.12B
$14.7K ﹤0.01%
5,000
FUL icon
1803
H.B. Fuller
FUL
$3.28B
$14.6K ﹤0.01%
217
-66
-23% -$4.96K
BLKB icon
1804
Blackbaud
BLKB
$2.08B
$14.6K ﹤0.01%
198
+50
+34% +$4.09K
VNET
1805
VNET Group
VNET
$2.09B
$14.6K ﹤0.01%
3,086
OWL icon
1806
Blue Owl Capital
OWL
$18.5B
$14.6K ﹤0.01%
626
+437
+231% +$10K
HRB icon
1807
H&R Block
HRB
$5.86B
$14.5K ﹤0.01%
275
+100
+57% +$5.88K
HP icon
1808
Helmerich & Payne
HP
$3.71B
$14.5K ﹤0.01%
453
-214
-32% -$7.26K
UMBF icon
1809
UMB Financial
UMBF
$11.1B
$14.4K ﹤0.01%
128
+34
+36% +$3.93K
PINC
1810
DELISTED
Premier
PINC
$14.4K ﹤0.01%
681
+134
+24% +$2.84K
PFC
1811
DELISTED
Premier Financial Corp. Common Stock
PFC
$14.4K ﹤0.01%
563
+13
+2% +$339
LINE
1812
Lineage Inc
LINE
$9.65B
$14.3K ﹤0.01%
245
+239
+3,983% +$16.2K
PCOR icon
1813
Procore
PCOR
$8.67B
$14.3K ﹤0.01%
191
+147
+334% +$10.4K
SRRK icon
1814
Scholar Rock
SRRK
$6.44B
$14.3K ﹤0.01%
331
+52
+19% +$1.69K
NWN icon
1815
Northwest Natural Holdings
NWN
$2.12B
$14.3K ﹤0.01%
361
+15
+4% +$612
CASY icon
1816
Casey's General Stores
CASY
$30.9B
$14.3K ﹤0.01%
36
-5
-12% -$2.02K
ADT icon
1817
ADT
ADT
$5.58B
$14.2K ﹤0.01%
2,057
+2,003
+3,709% +$14.6K
CIG icon
1818
CEMIG Preferred Shares
CIG
$6.01B
$14.2K ﹤0.01%
7,998
-1,894
-19% -$3.68K
PRGS icon
1819
Progress Software
PRGS
$1.76B
$14.1K ﹤0.01%
217
+71
+49% +$4.74K
BPMC
1820
DELISTED
Blueprint Medicines
BPMC
$14.1K ﹤0.01%
162
+134
+479% +$12.3K
BIO icon
1821
Bio-Rad Laboratories Class A
BIO
$9.42B
$14.1K ﹤0.01%
43
+10
+30% +$3.39K
SRPT icon
1822
Sarepta Therapeutics
SRPT
$1.77B
$14.1K ﹤0.01%
116
+78
+205% +$9.56K
TDS icon
1823
Telephone and Data Systems
TDS
$3.75B
$14.1K ﹤0.01%
413
-171
-29% -$5.2K
MC icon
1824
Moelis & Co
MC
$4.94B
$14K ﹤0.01%
190
+67
+54% +$4.85K
FIBK icon
1825
First Interstate BancSystem
FIBK
$3.58B
$14K ﹤0.01%
432
-5
-1% -$163

Similar funds

EverSource Wealth Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, EverSource Wealth Advisors held 3,857 positions worth $1.78B, up 13% from $1.58B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

EverSource Wealth Advisors deployed $179M of net new capital in Q4 2024, opening 813 new positions and adding to 1,811 existing holdings. Its largest new stake was ProShares Ultra Russell2000: 86,694 shares worth $3.63M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 12% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Health Care ETF, an estimated $7.05M trimmed.

  • EverSource Wealth Advisors's largest Q4 2024 buy was ProShares Ultra Russell2000: 86,694 shares worth $3.63M.
  • EverSource Wealth Advisors added most to Pacer US Cash Cows 100 ETF in Q4 2024, an estimated $7.51M increase.
  • EverSource Wealth Advisors's biggest Q4 2024 reduction was Vanguard Health Care ETF, cutting an estimated $7.05M.
  • EverSource Wealth Advisors fully exited iShares Global Comm Services ETF in Q4 2024, selling an estimated $2.74M.
  • EverSource Wealth Advisors's ten largest holdings make up 23% of its $1.78B portfolio in Q4 2024.
  • EverSource Wealth Advisors opened 813 new positions and closed 107 in Q4 2024.
  • EverSource Wealth Advisors's portfolio value rose 13% quarter-over-quarter to $1.78B.

Based on EverSource Wealth Advisors's 13F filing for Q4 2024, filed 10 Feb 2025.